NewsTeclistamab Promising as a Treatment of Last Resort for Refractory Autoimmune DiseasesAuthor:Edited by Lucy Hicks Publish date: September 5, 2024In small studies, teclistamab significantly improved autoimmune disease activity and demonstrated a good safety profile. Read More
